Rhenman & Partners Asset Management’s Exact Sciences EXAS Stock Holding History

Rhenman & Partners Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-348,000	Closed	-$19M	–	100
2025 Q3	$19M	Sell	348,000 -2,000	-0.6%	-$99.9K	2.11%	15
2025 Q2	$18.6M	Sell	350,000 -90,000	-20%	-$4.57M	2.35%	12
2025 Q1	$19M	Sell	440,000 -31,000	-7%	-$1.57M	2.19%	18
2024 Q4	$26.5M	Buy	471,000 +6,000	+1%	+$373K	2.72%	9
2024 Q3	$31.7M	Buy	465,000 +320,000	+221%	+$18.1M	2.57%	9
2024 Q2	$6.13M	Buy	145,000 +2,000	+1%	+$110K	0.59%	48
2024 Q1	$9.88M	Sell	143,000 -22,000	-13%	-$1.39M	0.94%	38
2023 Q4	$12.2M	Buy	165,000 +5,000	+3%	+$328K	1.22%	31
2023 Q3	$10.9M	Sell	160,000 -15,000	-9%	-$1.27M	1.18%	32
2023 Q2	$16.4M	Buy	175,000 +85,000	+94%	+$6.63M	1.73%	26
2023 Q1	$5.96M	Sell	90,000 -20,000	-18%	-$1.29M	0.65%	52
2022 Q4	$5.45M	Buy	110,000 +34,000	+45%	+$1.39M	0.57%	59
2022 Q3	$2.64M	Hold	76,000	–	–	0.28%	77
2022 Q2	$2.99M	Hold	76,000	–	–	0.34%	65
2022 Q1	$5.31M	Sell	76,000 -34,000	-31%	-$2.49M	0.52%	59
2021 Q4	$8.57M	Sell	110,000 -70,000	-39%	-$6.18M	0.57%	59
2021 Q3	$17.2M	Buy	180,000 +25,000	+16%	+$2.64M	1.21%	38
2021 Q2	$19.3M	Sell	155,000 -20,000	-11%	-$2.39M	1.31%	35
2021 Q1	$23.1M	Buy	175,000 +100,000	+133%	+$13.7M	1.61%	23
2020 Q4	$9.94M	Sell	75,000 -5,000	-6%	-$605K	0.81%	51
2020 Q3	$8.16M	Hold	80,000	–	–	0.73%	51
2020 Q2	$6.96M	Sell	80,000 -24,300	-23%	-$1.94M	0.75%	50
2020 Q1	$6.05M	Sell	104,300 -2,700	-3%	-$219K	0.85%	45
2019 Q4	$9.89M	Sell	107,000 -786	-0.7%	-$69.1K	1.08%	41
2019 Q3	$9.74M	Buy	107,786 +17,786	+20%	+$2.03M	1.22%	34
2019 Q2	$10.6M	Sell	90,000 -10,000	-10%	-$1.01M	1.17%	36
2019 Q1	$8.66M	Buy	+100,000	New	+$8.51M	1.01%	40

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rhenman & Partners Asset Management's EXAS Position: Q4 2025 in Review

Rhenman & Partners Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 348,000 shares — an estimated $19M sold.

Rhenman & Partners Asset Management first reported a position in EXAS in Q1 2019 and held it in 27 quarters. The position peaked at $31.7M in Q3 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Rhenman & Partners Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Rhenman & Partners Asset Management sold 348,000 Exact Sciences shares in Q4 2025, an estimated $19M.
Rhenman & Partners Asset Management first reported a position in Exact Sciences in Q1 2019 and held it in 27 quarters.
Rhenman & Partners Asset Management's Exact Sciences position peaked at $31.7M in Q3 2024.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.